Press release
USD 36 Billion, Generic Oncology Drugs Market Size to hit 6.3% of CAGR by 2027 - The Insight Partners
The Insight Partners
Generic Oncology Drugs Market to 2027 - Global Analysis and Forecasts by Molecular Type (Large Molecule, Small Molecule); Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Cervical Cancer, Others), and Geography
Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00006393?utm_source=OpenPR&utm_medium=10051
Some of the prominent players operating in the generic oncology drugs market are Teva Pharmaceutical Industries Ltd., Sandoz International GMBH, Glenmark, Sun Pharmaceutical Industries Ltd, MSN Laboratories, Aurobindo Pharma, Intas Pharmaceuticals, Zydus Cadila, Mylan N.V., Cipla Inc., Fresenius Kabi AG, and Dr. Reddy's Laboratories Ltd., among others. The market players are focused on bringing new and innovative products and services through various inorganic strategies such as acquisitions and mergers to sustain their position in the market. Recently in July 2019, Drug maker Pfizer Inc. has agreed to spin off its generic drugs business and combine it with Mylan, a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar
Growing Applications of Generic Oncology Drugs in Healthcare to Drive Generic Oncology Drugs in Healthcare Market Growth
Cancer is one of the leading cause of deaths across the globe and is extremely affecting the quality of life. Thus, cancer will be burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately, 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases will be diagnosed in the US.
Additionally, cancer is found to be common in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in UK were due to cancer.
Furthermore, Asia Pacific region is also facing the problem of growing prevalence of cancer. The top 15 countries with
Cancer prevalence are: Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia. According to the National Institute of Cancer Prevention and Research (NICPR), in 2018, in India total deaths due to cancer were 784,821.
These statistics determine an increase in the demand for advanced cancer diagnostics in various regions across the globe. Thus driving the growth of generic oncology drugs during the forecast period.
The market for generic cancer drugs is driven by frequent drug launches. Most of the major market players are involved in the manufacturing wide range of generic cancer drugs that help in reducing cost of cancer care. For instance, in July 2019, Lupin Pharmaceuticals, Inc. launched a generic Imatinib Mesylate tablets used to treat certain types of cancer.
Additionally April 2019, Emcure Pharmaceuticals, a leading pharmaceutical company from India launched world's first generic Eribulin for treatment of metastatic breast cancer.
Emcure is marketing the drug with brand name 'Eribilin', that offers high-quality and cost-effective treatment option to breast cancer patients in India. The medicine Eribilin is Eisai pharmaceutical's generic version of expired patent product.
Moreover, in January 2019, Hetero Healthcare Ltd launched a new generic Lapatinib tablets, which are used to treat metastatic breast cancer in India. The tablets are consumed along with Capecitabine or Letrozole, that together, inhibit the growth of cancer cells in patients. Thus, the constant developments in generic oncology drugs accelerate the market growth during the forecast period.
Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00006393?utm_source=OpenPR&utm_medium=10051
Also:
Superalloys Market
https://www.marketwatch.com/press-release/superalloys-market-growth-size-forecasts-2028-danyang-city-kaixin-alloy-material-crs-holdings-special-quality-alloys-arconic-inc-forged-solutions-group-2022-09-29
Smart Coatings Market
https://www.marketwatch.com/press-release/superalloys-market-growth-size-forecasts-2028-danyang-city-kaixin-alloy-material-crs-holdings-special-quality-alloys-arconic-inc-forged-solutions-group-2022-09-29
Shotcrete Market
https://www.marketwatch.com/press-release/smart-coatings-market-new-technologies-with-growth-prospectus-by-2028-2022-09-29
White Spirits Market
https://www.marketwatch.com/press-release/white-spirits-market-global-industry-analysis-size-share-trends-growth-and-forecast---2028-2022-09-29
Green Coating Market
https://www.marketwatch.com/press-release/green-coating-market-size-share-global-opportunities-trends-regional-overview-global-growth-leading-company-analysis-and-key-country-forecast-to-2028-2022-09-29
Email: sales@theinsightpartners.com
Phone : +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release USD 36 Billion, Generic Oncology Drugs Market Size to hit 6.3% of CAGR by 2027 - The Insight Partners here
News-ID: 2755209 • Views: …
More Releases from The Insight Partners
A Complete Study Guide to Luxury Wines
The Luxury Wines Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Download PDF:- https://www.theinsightpartners.com/sample/TIPRE00020680?utm_source=Openpr&utm_medium=10503
Top Key Major Players:-
Bacardi and Company Limited
Bayadera Group
Brown Forman
Davide Campari-Milano N.V.
Diageo
Edrington
LVMH
Pernod Ricard
SUNTORY HOLDINGS LIMITED.
About Us:
The Insight Partners…
A Complete Study Guide to Antimicrobial Coating
The antimicrobial coating market size is projected to reach US$ 15.98 billion by 2031 from US$ 7.64 billion in 2024. The market is expected to register a CAGR of 11.1% during 2025-2031. The development of sustainable and eco-friendly antimicrobial coating is likely to bring new trends in the market during the forecast period.
Download PDF:- https://www.theinsightpartners.com/sample/TIPRE00009037?utm_source=Openpr&utm_medium=10503
Top Key Major Players:-
Cupron Inc
ALISTAGEN Corp
Fiberlock Technologies
The Sherwin-Williams Co
PPG Industries Inc
Akzo Nobel NV
CytaCoat AB
Nano-Care Deutschland AG
Specialty…
A Complete Study Guide to Flexible Packaging
flexible packaging market is projected to reach US$ 237,975.67 million by 2028 from US$ 176,173.61 million in 2021; it is expected to grow at a CAGR of 4.4% from 2021 to 2028. Flexible packaging includes liners, pouches, seals, sample packets, and bags. It can be composed of film, plastic, paper, foil, etc. It is used for various food and beverage items, consumer products, music CDs, pharmaceuticals, computer software packages, and…
A Complete Study Guide to Anti-Money Laundering
The Anti-Money Laundering Market size is projected to reach US$ 13.54 billion by 2031 from US$ 4.21 billion in 2024. The market is expected to register a CAGR of 18.3% during 2025-2031. The increasing regulatory pressure, rising financial crimes, and the global expansion of digital banking and fintech services are key factors driving anti-money laundering market growth. Governments and regulatory bodies are enforcing stricter compliance measures to combat money laundering,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
